Home » Topics » Endocrine/metabolic, BioWorld Science

Endocrine/metabolic, BioWorld Science
RSS

Prevention of bone loss with alendronate

Sep. 20, 1996

Endocrine research at Toyama

Sep. 13, 1996

Endocrine R&D at Chugai

Sep. 13, 1996

A safe, effective and economical contraceptive method

Sep. 13, 1996

Danish approval for testosterone patch

Sep. 13, 1996

Orally active GH secretagogues with a short duration of action

Sep. 13, 1996

New treatment for diabetic keratopathy

Sep. 13, 1996

Achiral inhibitors of carnitine palmitoyltransferase I

Sep. 13, 1996

Chugai's metabolic drug R&D pipeline

Sep. 13, 1996

Rapamycin in anemia

Sep. 13, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 2, 2026.
Small-molecule TREM2 agonist advances to treat Alzheimer’s
BioWorld Science
Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...
Amlogenyx’s AM-805 reduces amyloid plaques in AD
BioWorld Science
The potent carboxypeptidase enzyme protective protein cathepsin A (PPCA) is known to cleave the C-terminus of amyloid-β42, responsible for aggregation and...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026
Atai Therapeutics patents new 5-HT2 receptor agonists
BioWorld Science
Atai Therapeutics Inc. has identified new 5-HT2 receptor agonists potentially useful for the treatment of psychiatric disorders.